Navigation Links
Breakthrough developments in rheumatoid arthritis reported

Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis. With these clinical features at his side, he turns to the basic building blocks of life – the human genome – to figure out what makes these people susceptible to the disabling inflammatory condition.

Dr. Gregersen has finally closed the circle between key genes identified in his laboratory at the Robert S. Boas Center for Genomics and Human Genetics at The Feinstein Institute for Medical Research in Manhasset, NY and more than a 1,000 patients with rheumatoid arthritis. The genes will help tell the story of how the immune system works to create specific antibodies that in turn increase a person’s risk for this crippling disease.

On Monday at the Federation of Clinical Immunology Services’ (FOCIS) meetings in San Diego, CA, Dr. Gregersen and his colleagues will be presenting the lab’s latest genetic findings. The group conducted genome-wide scans to identify polymorphisms, or genetic variants, that are associated with the inflammatory condition and can be used to understand the triggers of the disease. This will provide key insights into the pathways underlying rheumatoid arthritis and other autoimmune diseases. It may ultimately provide tests to predict who will respond to the available new treatments. Franak Batliwalla, PhD, also of The Feinstein Institute, will be presenting related studies on biomarkers and genetic influences on drug response at the same meeting.

Identifying Immune System Mediators

About one percent of the US population will develop rheumatoid arthritis, an autoimmune disease that leads to painful joint swelling. Scientists are cracking the genetic code that makes the immune system wage an attack on a person’s joints. Over the last decade, Dr. Gregersen and his colleagues have been amassing a genetic database complete with sibl
'"/>

Source:North Shore-Long Island Jewish (LIJ) Health System


Page: 1 2 3 4

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
3. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
4. Breakthrough isolating embryo-quality stem cells from blood
5. Breakthrough System for Understanding Ocean Plant Life Announced
6. Breakthrough: Scientists create worlds tiniest organic particles
7. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
8. Sciences Breakthrough of the Year: Watching evolution in action
9. Breakthrough for stem cell research
10. Breakthrough in understanding type-2 diabetes as key genes identified
11. Breakthrough vaccine to treat chemo-resistant ovarian cancer

Post Your Comments:
(Date:11/23/2009)..., November 16, 2009 -- A USDOE and USDA study conc... cropland, and cropland pasture could be converted...grasses, such as switchgrass, from which biomass c...Economically viable production of a perennial gras... biomass are removed annually is expected to requi...
(Date:11/23/2009)....H. University of New Hampshire microbiologist Lo... to advance understanding of the actinorhizal plan...ch nutrient-poor and contaminated soils. , The ...rded Tisa, a professor of molecular, cellular and ...otic relationship between the bacteria Frankia and...
(Date:11/23/2009)...y of Southern California biomedical engineer and c...new tool to help clinicians distinguish cardiac em... problems manageable with drugs and lifestyle chan...ted into the arteries feeding the heart, offer an ...hese blood vessels, often revealing deposits of a ...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Nektar Therapeutics Promotes Lorianne Masuoka M D to Chief Medical Officer 12543 1Nektar Therapeutics Promotes Lorianne Masuoka M D to Chief Medical Officer 12543 2Nektar Therapeutics Promotes Lorianne Masuoka M D to Chief Medical Officer 12543 3Keryx Biopharmaceuticals Inc Receives Extension for Nasdaq Listing Compliance 48281 1Keryx Biopharmaceuticals Inc Receives Extension for Nasdaq Listing Compliance 48281 2Keryx Biopharmaceuticals Inc Receives Extension for Nasdaq Listing Compliance 48281 3The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 1The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 2
...cillations and Neurite Growth ,Kazunori Kanemaru... This week, Kanemaru et al. explore the signaling ... cultured astrocytes and the promotion of neurite ...ne-bound adhesion molecule N-cadherin. The authors...ignaling with retroviral-mediated expression of IP...
...it is overwhelmingly likely that life began in spa... scientists. , Professor Chandra Wickramasinghe a...iology have,long argued the case for panspermia - ...spread to,habitable planets across the galaxy. A r...nt of,the,theory. , Now the team claims that find...
...tive apparatus of a model virus is bolstering the ...se that cause important human diseases such as AID...that could eventually make them vulnerable to broa...ed today (Aug. 14) in the online, open-access jour...esearchers from the Howard Hughes Medical Institut...
Other Biology News:News tips from the Journal of Neuroscience 2News tips from the Journal of Neuroscience 3Features of replication suggest viruses have common themes, vulnerabilities 2Features of replication suggest viruses have common themes, vulnerabilities 3
(Date:11/20/2009)... , , STOCKHOLM, November 20 /PRNew...d that the European Investment Fund (EIF) has ente...y. The co-investment fund will be,managed by Karol...y,s,portfolio of early-stage pharmaceutical and me...st 26.7 M Euros in the co-investment fund. The agr...
(Date:11/19/2009)... , , COPENHAGEN, Nov. 19 Da...d Inbicon cellulosic ethanol plant in Kalundborg, ...s one of the world,s first and largest 2nd generat...s Accellerase enzymes are used in the plant,s inno...cor, a Division of Danisco, was the first to marke...
(Date:11/19/2009)... , , BETHESDA, Md., Nov. 19 /PRNewswire-Fi... an innovator in biotechnology for diabetes therap...ulting services to food, supplement, biotechnology... results of Tuesday,s Annual Meeting of Shareholde...Incorporated (Nasdaq: SPEX ) elected the followin...
(Date:11/19/2009)... , World,s Top Gene Synth...onsortium (IGSC) to Coordinate Best Practices in R...0 Percent of Worldwide Gene Synthesis Capacity , ...-- Five of the world’s leading gene synthesi...ll apply a common screening protocol to promote bi...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...Innovative Fall Detection ... - Falls are the leading cause,of accidental death...NIA),part of the National Institutes of Health (NI...ess Innovation Research grant entitled,"Non-Intrus...ing System for,the Elderly". The research aims to ...
...N) and Cowen Healthcare Royalty Partners ("CHRP") ...HRP team through the addition of several new,hires...s founders Todd C. Davis,and Clarke B. Futch, the ...,launch this initiative, as previously announced. ...and strengthen its,team through the addition of se...
...rp. (Nasdaq: GENZ ) and Sunway Biotech Co. Ltd. a...acture, develop, and commercialize the,experimenta... Genzyme,s,most advanced gene therapy candidate an...United States and Europe. Sunway is a privately-h...in 1995. It is one of only two companies in the wo...
Other Biology Technology:Leading Edge Research Underway in Fall Prevention for Seniors 2Leading Edge Research Underway in Fall Prevention for Seniors 3Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 2Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 3Genzyme and Sunway to Collaborate on Gene Therapy Program in China 2Genzyme and Sunway to Collaborate on Gene Therapy Program in China 3Genzyme and Sunway to Collaborate on Gene Therapy Program in China 4
...dom EVO96R and Freedom EVO384R are fast multi-chan...t, available in three different sizes, with a mult... deliver significant time saving, with true parall...f your assays with the Freedom EVOware program. ...
Bovine Serum, Sterile Filtered from Meridian Life Science, Inc.
Bromophenol Blue sodium salt from Sigma-Aldrich
Blue Magnet from StemCell Technologies, Inc.
Biology Products: